Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BlueWillow Biologics

Request full access

BlueWillow Biologics is a privately-held biopharmaceutical company

Ann Arbor, United StatesFounded 2000Biotech & Life Sciences

About BlueWillow Biologics

BlueWillow Biologics is a clinical-stage biotechnology company specializing in the development of intranasal vaccines and immunotherapies. The company operates in the biotechnology and healthcare markets, focusing on creating vaccines that can be administered through the nasal route. BlueWillow's proprietary oil-in-water emulsion adjuvant technology enhances the immune response by delivering antigens directly to the mucosal surfaces, which are the body's first line of defense against pathogens. This technology has shown compatibility with a broad range of antigens, making it versatile for various vaccine candidates. The company primarily serves healthcare providers, research institutions, and government agencies involved in public health and biodefense. BlueWillow's business model revolves around the development and licensing of its vaccine platform, as well as partnerships for clinical trials and commercialization. Revenue is generated through licensing agreements, research grants, and potential future sales of approved vaccines. The company has demonstrated human safety in over 400 clinical trial participants and continues to advance its pipeline of intranasal vaccines.

Source: Dealroom company data

At a glance

Status
Operational
Employees
21
Open positions
None listed
Dealroom signal
28.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology
Deep Tech, Nanotech
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Sep 2018 — — Small Business Innovation Research —
EARLY VCOther financing May 2018 $10M $40M North Coast Technology Investors —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

BlueWillow Biologics website traffic

Latest recorded traffic for BlueWillow Biologics is 1.9K monthly website visits, down 9.5% over the last three months. BlueWillow Biologics's team grew 0% over the past year.

Latest monthly visits1.9K 3-month web change-9.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BlueWillow Biologics in the Ann Arbor ecosystem

Live from Dealroom

The BlueWillow Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A3 investors entered at this stage

  • Perseus
  • Venture Investors Health Fund
  • North Coast Technology Investors
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BlueWillow Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BlueWillow Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.